190 related articles for article (PubMed ID: 20035905)
21. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
22. Magnesium-based bone implants: immunohistochemical analysis of peri-implant osteogenesis by evaluation of osteopontin and osteocalcin expression.
Bondarenko A; Angrisani N; Meyer-Lindenberg A; Seitz JM; Waizy H; Reifenrath J
J Biomed Mater Res A; 2014 May; 102(5):1449-57. PubMed ID: 23765602
[TBL] [Abstract][Full Text] [Related]
23. High extracellular calcium stimulates osteoclast-like cell formation and bone-resorbing activity in the presence of osteoblastic cells.
Kaji H; Sugimoto T; Kanatani M; Chihara K
J Bone Miner Res; 1996 Jul; 11(7):912-20. PubMed ID: 8797111
[TBL] [Abstract][Full Text] [Related]
24. In vivo corrosion behavior of Mg-Mn-Zn alloy for bone implant application.
Xu L; Yu G; Zhang E; Pan F; Yang K
J Biomed Mater Res A; 2007 Dec; 83(3):703-11. PubMed ID: 17549695
[TBL] [Abstract][Full Text] [Related]
25. Early changes of bone histology and circulating markers of bone turnover after parathyroidectomy in hemodialysis patients with severe hyperparathyroidism.
Yajima A; Tanaka K; Tominaga Y; Ogawa Y; Tanizawa T; Inou T; Otsubo O; Otsubo K
Clin Nephrol; 2001 Jul; 56(1):27-34. PubMed ID: 11499656
[TBL] [Abstract][Full Text] [Related]
26. In vivo stimulation of bone formation by aluminum and oxygen plasma surface-modified magnesium implants.
Wong HM; Zhao Y; Tam V; Wu S; Chu PK; Zheng Y; To MK; Leung FK; Luk KD; Cheung KM; Yeung KW
Biomaterials; 2013 Dec; 34(38):9863-76. PubMed ID: 24060425
[TBL] [Abstract][Full Text] [Related]
27. Effect of sevelamer hydrochloride on bone in experimental uremic rats.
Kuwahara M; Inoshita S; Terada Y; Sasaki S
Ther Apher Dial; 2009 Feb; 13(1):42-8. PubMed ID: 19379169
[TBL] [Abstract][Full Text] [Related]
28. Magnesium deficiency: effect on bone and mineral metabolism in the mouse.
Rude RK; Gruber HE; Wei LY; Frausto A; Mills BG
Calcif Tissue Int; 2003 Jan; 72(1):32-41. PubMed ID: 12370796
[TBL] [Abstract][Full Text] [Related]
29. Peri-implant osteogenesis in health and osteoporosis.
Marco F; Milena F; Gianluca G; Vittoria O
Micron; 2005; 36(7-8):630-44. PubMed ID: 16182543
[TBL] [Abstract][Full Text] [Related]
30. The effect of simvastatin on bone formation and ceramic resorption in a peri-implant defect model.
Ma B; Clarke SA; Brooks RA; Rushton N
Acta Biomater; 2008 Jan; 4(1):149-55. PubMed ID: 17702682
[TBL] [Abstract][Full Text] [Related]
31. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
[TBL] [Abstract][Full Text] [Related]
32. Relationship between bone ingrowth, mineral apposition rate, and osteoblast activity.
Bloebaum RD; Willie BM; Mitchell BS; Hofmann AA
J Biomed Mater Res A; 2007 May; 81(2):505-14. PubMed ID: 17236212
[TBL] [Abstract][Full Text] [Related]
33. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
34. Effect of low doses of stable strontium on bone metabolism in rats.
Marie PJ; Garba MT; Hott M; Miravet L
Miner Electrolyte Metab; 1985; 11(1):5-13. PubMed ID: 3974537
[TBL] [Abstract][Full Text] [Related]
35. The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts.
Yang L; Perez-Amodio S; Barrère-de Groot FY; Everts V; van Blitterswijk CA; Habibovic P
Biomaterials; 2010 Apr; 31(11):2976-89. PubMed ID: 20122718
[TBL] [Abstract][Full Text] [Related]
36. Bone-cell changes in estrogen-induced bone-mass increase in mice: dissociation of osteoclasts from bone surfaces.
Liu CC; Howard GA
Anat Rec; 1991 Feb; 229(2):240-50. PubMed ID: 2012311
[TBL] [Abstract][Full Text] [Related]
37. Effects of 1,25 dihydroxyvitamin D on osteoclast number and cytochemistry in normal and osteopetrotic (os) rabbits.
Grise MA; Marks SC; MacKay CA; Popoff SN
Am J Anat; 1990 Nov; 189(3):261-6. PubMed ID: 2148052
[TBL] [Abstract][Full Text] [Related]
38. Tetracyclines inhibit rat osteoclast formation and activity in vitro and affect bone turnover in young rats in vivo.
Zhou X; Zhang P; Zhang C; An B; Zhu Z
Calcif Tissue Int; 2010 Feb; 86(2):163-71. PubMed ID: 20033141
[TBL] [Abstract][Full Text] [Related]
39. Dietary magnesium reduction to 25% of nutrient requirement disrupts bone and mineral metabolism in the rat.
Rude RK; Gruber HE; Norton HJ; Wei LY; Frausto A; Kilburn J
Bone; 2005 Aug; 37(2):211-9. PubMed ID: 15923157
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable magnesium scaffolds: Part II: peri-implant bone remodeling.
Witte F; Ulrich H; Palm C; Willbold E
J Biomed Mater Res A; 2007 Jun; 81(3):757-65. PubMed ID: 17390322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
